Perlmutter Cancer Center

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

• Conditions:
  Pancreatic Cancer
• Age: Between 18 years - 99 years
• Gender: Male or Female

• Other Inclusion Criteria:
  

  1) Histological/cytological diagnosis of de novo adenocarcinoma of the pancreas 2) Amendable & assigned by the investigator to receive therapy with gemcitabine & nab-paclitaxel
  

You may not be eligible for this study if the following are true:

• 1) Prior palliative treatment (e.g. surgery, radiation) to the tumor 2) Cancer requiring anti-tumor treatment within the 5 years before inclusion, excluding treated stage I prostate cancer, in situ cervical or uterus cancer, in situ breast cancer and non-melanomatous skin cancer. 3) Concurrent anti-tumor therapy beyond gemcitabine and nab-paclitaxel 4) Implantable electronic medical devices in the torso, such as pacemakers